Clinical Trial Update: Use of the Paradigm 722 System to Improve Glycemic Control in Adult and Adolescent Subjects With Type 1 Diabetes [NA]

View source ↗

Summary

A clinical trial update on the Paradigm 722 System from Medtronic evaluating its ability to improve glycemic control in adult and adolescent patients with Type …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Paradigm 722 System

Snippet

Sponsor: Medtronic MiniMed, Inc. | Conditions: Type 1 Diabetes | NA | Status: COMPLETED | Results posted: 2011-04-29